![](https://dbtnews.com/wp-content/uploads/2020/01/Image-40-300x199.webp)
Takeda Pharmaceutical Co ADR [TAK] stock Upgrade by BofA Securities analyst, price target now $20
Takeda Pharmaceutical Co ADR [NYSE: TAK] price surged by 0.66 percent to reach at $0.09. The one-year TAK stock forecast points to a potential upside of 9.05. The average equity rating for TAK stock is currently 2.12, trading closer to a bullish pattern in the